Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03424382 · ClinicalTrials.gov registry record
CREATION Health Readmission Risk Assessment Tool
A clinical trial, sponsored by AdventHealth.
- Completed
- Registry status
- 1,218
- Enrollment target
NCT03424382 is a clinical trial that has completed, run by AdventHealth. The registered enrollment target is 1,218 participants.
The verdict
NCT03424382 has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- 1,218 participants
- Enrollment target
Study Summary
This study occurs in two phases. Phase 1 involves initial item development and measurement validation of a new tool for identifying hospitalized patients at high risk for preventable readmission. Primary tasks include item construction and content validation, data collection, analysis, and instrument refinement. Phase 2 involves administering the refined instrument to a new group of patients to determine final item content for the instrument, its factor structure, and its predictive validity.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,218 participants |
| Start Date | 2017-05-15 |
| Est. Completion | 2019-11-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03424382
The ClinicalTrials.gov registry entry for NCT03424382 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,218 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03424382 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03424382 about?
NCT03424382 is a clinical study titled "CREATION Health Readmission Risk Assessment Tool". This study occurs in two phases. Phase 1 involves initial item development and measurement validation of a new tool for identifying hospitalized patients at high risk for preventable readmission. Primary tasks include item construction and content validation, data collection, analysis, and instrumen...
What is the current status of trial NCT03424382?
This trial is currently completed. The enrollment target is 1,218 participants. The study started on 2017-05-15. Estimated completion is 2019-11-26.
Who is sponsoring clinical trial NCT03424382?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.